about
Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 geneHow can technology enhance cognitive behavioral therapy: the case of pediatric obsessive compulsive disorderQuality of life in children with OCD with and without comorbidity.Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trialTics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods.Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.Structure and clinical correlates of obsessive-compulsive symptoms in a large sample of children and adolescents: a factor analytic study across five nations.Subclinical autism spectrum symptoms in pediatric obsessive-compulsive disorder.Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder.Treatment of a Child With Obsessive-Compulsive Disorder With Limited Motivation: Course and Outcome of Cognitive-Behavior Therapy.One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.Quality of life in children with OCD before and after treatment.[Asperger syndrome in a Norwegian county 2005-08].Developmental course of anxiety and depression from adolescence to young adulthood in a prospective Norwegian clinical cohort.Effectiveness of cognitive behavior treatment for pediatric obsessive-compulsive disorder: acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS).Obsessive-compulsive symptom dimensions: Association with comorbidity profiles and cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder[Infant swimming programs in Norway during the last 10 years][Simpson-Golabi-Behmel syndrome. A new overgrowth syndrome with increased risk of tumor development]Are peer support groups for adolescents with Asperger's syndrome helpful?Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test-retest reliabilityIs it time to rethink standard dosage of exposure-based cognitive behavioral therapy for pediatric obsessive-compulsive disorder?Hoarding in children and adolescents with obsessive-compulsive disorder: prevalence, clinical correlates, and cognitive behavioral therapy outcomeDistinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatmentTreatment Gains Are Sustainable in Pediatric Obsessive-Compulsive Disorder: Three-Year Follow-Up From the NordLOTSAge of First Walking and Associations with Symptom Severity in Children with Suspected or Diagnosed Autism Spectrum DisorderConvergent and divergent validity of the schedule for affective disorders and schizophrenia for school-age children - present and lifetime version diagnoses in a sample of children and adolescents with obsessive-compulsive disorder
P50
Q28144537-0705402E-B7EA-45EF-83C0-0D6043BC14E7Q33455217-077DA061-808A-4CAE-AC25-2DA78F4F1A57Q34537521-78BAD9DC-787B-4FDB-816C-A2D73A7768F2Q35568012-B4AB1CFE-16DD-4C98-AC92-1A3AA4F3E435Q35816517-9E816939-8BC7-48C5-8475-16DB0792070CQ36078465-B47E2AEA-F23D-4C66-AD90-0988EE403DDAQ37426116-6C4BBAF9-2671-446F-B863-299297DB69E4Q38365635-DC82EF77-FCAE-4484-A135-58163BB8C38EQ39623701-2EA5228C-7C81-4615-9DCB-B2A91E79F097Q40373805-6E2F2ED4-3E3D-4452-9B9F-E6C4AF3DA06CQ42693836-19E03CE2-F9DF-48AF-A66F-D75CCFA72672Q47394677-8A9D2273-0A9B-4DA4-98F3-71A2ACFE8CC4Q47582889-9FCE72EE-364B-45E4-8330-136FE61BCB47Q48055578-1475A289-EA4B-4B04-83C9-8301B697F183Q50311923-3D4B6552-4935-4043-B1B1-C5503ECAF0BFQ50420983-14B01A0F-C4C0-4ADB-A364-9ED00A60B755Q50608517-ABAE9E5F-699B-4789-A97F-2BA660D23983Q57070870-F65D8138-2831-4A98-BEC3-81AE97D2C27BQ68666993-10D115E7-01FF-4F98-9F46-B67B9A692AF1Q74619109-CFC6D6B3-DA83-4DD0-8658-A2BFDD5F38E3Q79333118-2774063B-8F69-4874-A31B-BEC06CCD5301Q90158776-9A557F23-9109-49B6-AC6A-11D4CF650D54Q90773036-B245443C-72A2-4A7E-86F0-F3343EDD792DQ91103748-1085C587-A3D8-4ED8-B78F-6052502AF011Q91313544-9A7032FE-8E9A-49A5-BBF6-B87F4C197241Q91618164-9A04630C-87D9-4E32-AD68-397F3DBD2ADBQ91667644-82E4B1D2-51F9-4D78-8A88-D3CC6CF27A55Q92355713-FA37608C-4B98-4340-9690-6A8CD551A6D5
P50
description
Forscher
@de
chercheur
@fr
forsker
@nb
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Bernhard Weidle
@en
Bernhard Weidle
@nb
Bernhard Weidle
@nl
Weidle B
@ast
Weidle B
@es
type
label
Bernhard Weidle
@en
Bernhard Weidle
@nb
Bernhard Weidle
@nl
Weidle B
@ast
Weidle B
@es
altLabel
Weidle B
@en
prefLabel
Bernhard Weidle
@en
Bernhard Weidle
@nb
Bernhard Weidle
@nl
Weidle B
@ast
Weidle B
@es
P1015
P1015
P106
P21
P31
P496
0000-0002-1822-7671